The vanilloid receptor type 1 (VR1) is a heat-activated ionophore preferentially expressed in nociceptive neurons of trigeminal and dorsal root ganglia (DRG). VR1, which binds and is activated by capsaicin and other vanilloid compounds, was noted to interact with the endocannabinoid anandamide (ANA) and certain inflammatory metabolites of arachidonic acid in a pH-dependent manner. At pH < 6.5 ANA induced 
C-fiber nociceptors are thin unmyelinated processes present throughout the body that respond to noxious stimuli including heat, tissue injury, acidification, and inflammation. Platelets, leukocytes, spinal cord astrocytes, and other cell types respond to tissue injury with eicosanoid release (1) (2) (3) . A linkage between generation of eicosanoids and pain sensation has been proposed; however, the range of mechanisms has not been fully determined (4) . A high proton (H ϩ ) concentration often coincides with inflammation, ischemia, and cancer growth (5, 6) . It is hypothesized that acidification and eicosanoid release during inflammation may synergize to produce nociceptor sensitization, but the molecular mechanisms require elucidation.
The recently identified vanilloid receptor/ionophore (VR1), 1 expressed in DRG and trigeminal ganglion neurons, is capable of integrating physical and chemical stimuli at the molecular level (7, 8) . Both noxious heat and vanilloid treatment evoke action potentials in primary sensory nociceptive neurons, and these effects are enhanced at a pH of less than 6.5 (8 -11 ). An acidic extracellular milieu increases the number of channels available to be opened by capsaicin (12) . However, H ϩ alone (i.e. pH 5.0 -6.0) does not activate VR1 in cultured DRG neurons (13) .
Chemodenervation with capsaicin has demonstrated that the majority of epidermal "C" type axons belong to the capsaicin/vanilloid-sensitive population of sensory neurons (14) . Capsazepine (CPZ), a well known antagonist of vanilloids, reduces hyperalgesic responses to inflammation, indicating that endogenous, vanilloid-like substances may be inhibited from acting via VR1 (15) . Although these nerve endings respond to capsaicin and other plant-derived vanilloids (16) , the endogenous pain signaling analog(s) of capsaicin have not been fully identified nor has their potential for toxicity been evaluated.
Recently, the endocannabinoid, anandamide (ANA), an analog of both eicosanoids and vanilloids, was shown to evoke inward current and depolarization in cells expressing recombinant VR1 (17) . Other arachidonic acid metabolites or analogs such as PGE 2 and arvanil, which are distant homologs of vanilloids, also are active on both their cognate receptors as well as on VR1 (18, 19) . The structural similarity of eicosanoids and vanilloids suggest that ANA and other metabolites of the lipoxigenase and cyclooxygenase pathways can "cross-talk" with VR1 under certain conditions. Although 12-and 15-(S)-hydroperoxyeicosatetraenoic acids, 5-and 15-(S)-hydroxyeicosatetraenoic acids, and leukotriene B (4) are currently reported to activate recombinant VR1 (4) , only a few eicosanoids, including prostaglandin, prostacyclin and PGE 2 , are reported to be proalgesic (20, 21) .
In contrast to the potential pro-algesic actions outlined above, ANA is much better known as an analgesic agent in persistent pain models through actions on the cannabinoid receptors, CB1 and CB2 (22, 23) . SR 141716A, a CB1-selective antagonist, reverses the behavioral effects of anandamidetreated rats, whereas other agonists are anti-allodynic in rats with persistent inflammation (24 -26) . In contrast to the analgesic actions of cannabinoids, little is known about the painrelated effects of endocannabinoids. ANA-induced Ca 2ϩ transport has recently been revealed in cells expressing recombinant human VR1 but not verified by Ca 2ϩ uptake experiments on nociceptive neurons (27) (28) (29) , and the physiological relevance of ANA-VR1 interaction continues to be debated (30, 31) .
It can be hypothesized that eicosanoids need other inflammatory factors, such as tissue acidification for their action on VR1. Thus, conditionally released or otherwise weak endogenous ligands at neutral pH can be potentiated by protonation of VR1. To study the potential role of arachidonic acid metabolites in pain signaling, assays were carried out on cultured DRG neurons and cells expressing C-terminally tagged recombinant versions of VR1. We used two methods to examine ligandinduced VR1 ionophore activity: 45 Ca 2ϩ uptake from the media and changes in [Ca 2ϩ ] i determined with calcium-sensitive fluorescent dye labeling and ratiometric confocal microscopy. Two rat VR1 expression constructs were examined. The first was a short, ⑀-epitope-tagged VR1 recombinant (VR1⑀) stably expressed in NIH 3T3 cells under the control of a weak cellular promoter. The second construct, a VR1-enhanced green fluorescent fusion protein (VR1eGFP), was used for the real time imaging of the dynamics of agonist-induced intracellular membrane remodeling in vivo. We have shown previously that membrane remodeling that involves ER (32) (33) (34) (35) and mitochondrial vesiculation (35) provides robust end points to assess agonistdriven Ca 2ϩ ionophore activity (35) . Confocal microscopy of vanilloid-or ANA-treated live DRG neurons and VR1eGFP-expressing cells disclosed an elevation of [Ca 2ϩ ] i , followed by fragmentation of the ER and mitochondria. The eicosanoid-induced Ca 2ϩ toxicity can result in intracellular dysfunction and axonal damage of VR1-positive DRG neurons. If the cell bodies of nociceptors are exposed to ANA or inflammatory eicosanoids, cell death may ensue through toxic accumulation of [Ca 2ϩ ] i . Our data suggest that low pH acts as a switch to convert VR1 to a form that binds ANA and eicosanoids. Thus, at low pH ANA and eicosanoids can have algesic or pro-algesic effects via VR1 at nociceptive endings as well as contribute to potential neuropathological processes in the peripheral nerve or sensory ganglia.
EXPERIMENTAL PROCEDURES
Recombinant Materials-C-terminally tagged chimeric rat VR1eGFP and VR1⑀ were prepared in the pEGFP-N3 (CLONTECH) and p⑀MTH (36) plasmid vectors, respectively, as described (35) . The plasmid constructs were transiently transfected in COS7, HEK293, and NIH 3T3 cells, and the expressed chimeric VR1 proteins were extensively characterized using biochemical and electrophysiological assays and fluorescence confocal microscopy (35) .
Transient Transfection-HEK 293 and COS7 cells (10 5 ) were plated on 25-mm glass slides for live cell confocal microscopy or seeded in 24-well plates for calcium transport experiments 1 day before transfection. GenePorter purchased from Gene Therapy Systems (San Diego, CA) was used as the transfection reagent. Transfections were carried out according to the recommendations of the manufacturer. For the 25-mm slides 3 g and for the 24-well plates 2 g of DNA/well were used together with 25 and 10 l of GenePorter reagent, respectively. The DNA and the GenePorter were mixed in serum free Opti-MEM (Life Technologies, Inc.) for 15 min at room temperature then placed on the cultured cells. After 3 h at 34°C the incubation medium was supplemented with an equal volume of complete Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum, 1% streptomycin, and 1% glutamine. To prevent acidification of the culture medium, the pH was buffered to 7.4 with 20 mM HEPES. To diminish heat-induced activation of VR1, cells were cultured in an incubator adjusted to 34°C. Transient transfected cells with green VR1eGFP fluorescence were counted on an inverted fluorescence microscope or quantified in a microplate fluorimeter at 515 nm, employing the 488 nm absorption band of eGFP.
Preparation of VR1⑀-expressing NIH 3T3 Cell Line-To develop cell lines permanently expressing VR1⑀, we used NIH 3T3 cells, which we determined to have a low endogenous level of Ca 2ϩ transport that was not inducible with vanilloids or ANA. To avoid toxicity that occurs with VR1 overexpression, VR1⑀ was expressed using only the basal activity of the metallothionein (pMTH) promoter. The C-terminal 12-amino acid ⑀-epitope allowed immunological detection and verification of ectopic expression. To prepare a cell line permanently expressing VR1⑀, NIH 3T3 cells were transiently transfected with the pMTH-VR1⑀ plasmid.
After 24 h cells were transferred into 24-well plates and incubated with complete DMEM and selection medium, containing 0.8 mg/ml geneticin (G418) buffered with 20 mM HEPES (pH 7.4) to stabilize the pH. Cell lines expressing VR1⑀ were selected at 34°C. In addition, to minimize heat-induced VR1 channel activation and Ca 2ϩ cytotoxicity, the selection medium was changed every second day. After 1 month G418-resistant colonies were tested with vanilloid-induced Ca 2ϩ transport assays. A colony exhibiting RTX-induced 45 Ca 2ϩ uptake 20-fold above the base line determined in comparison with parental NIH3T3 cells was chosen for further studies.
DRG Culture-DRG neuron-enriched cultures were prepared from embryonic rats (embryonic day 16) (35) . Briefly, DRGs were dissected and then processed in fresh dissection medium (Lebowitz medium; Life Technologies, Inc.) until plated in DMEM. The DMEM contained 20 mM HEPES (to prevent acidification and stabilize pH at 7.4), 7.5% fetal bovine serum, 7.5% horse serum, 5 mg/ml uridine supplemented with 2 mg/ml 5-fluoro-2Ј-deoxyuridine, and 40 ng/ml nerve growth factor to inhibit cell division and to promote differentiation of long neuronal processes, respectively. Cells were seeded on 25-mm glass coverslips or on multi-well microtiter plates. Surfaces were coated with poly-D-lysine and laminin. The cultures were selected in this medium for 1 week, at which point well differentiated neurons and nondividing cells dominated the population. Primary DRG cultures in this stage were used in Ca 2ϩ transport assays and confocal microscopy. 45 Ca 2ϩ transport assays were performed on NIH 3T3 cells permanently expressing the ⑀-tagged VR1 under control of the basal activity of the metallothionein promoter.
The cells were washed once in Hanks' balanced salt solution (pH 6.0) supplemented with 10 M Ca 2ϩ and 0.1 mg/ml bovine serum albumin (HCB) and adapted to room temperature (24°C) for 5 min. 45 Ca 2ϩ uptake was performed for 10 min at 24°C in HCB using 0.2 Ci of 45 Ca 2ϩ as radioactive tracer in a 200-l final volume. To determine the pH dependence of the 45 Ca 2ϩ uptake, HCB was buffered with 20 mM Tris-HCl, adjusted to the indicated pH with 1 M MES (HCBTM). Anandamide was prepared in a Soya oil/water (1:4) emulsion. RTX and CAP were diluted at least 10,000-fold from 10 mM ethanol stock solutions to the indicated final concentrations. To stop 45 Ca 2ϩ uptake, cells were rapidly changed back into 1 ml of HCB, washed two additional times with 1 ml HCB, and then lysed in 200 l/well RIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.5% deoxycholate, 0.1% SDS, 5 mM EDTA) for 30 min. Aliquots of the solubilized cell extracts were counted in a liquid scintillation counter.
[ 3 H]ANA Binding-Transfected HEK293 cells (10 5 /well) expressing VR1eGFP for 48 h were washed once in Ca 2ϩ -free Hanks' balanced salt solution (pH 6.0) supplemented with 0.1 mg/ml bovine serum albumin (HB). Binding experiments were performed for 40 min at 4°C in HB, except as radioactive tracer 0.5 Ci of [ 3 H]ANA/ml was added in 500 l incubation volume. To stop the binding, cells were rapidly changed back into 1 ml of ice-cold HB and washed rapidly two additional times with HB at 4°C. The cells were lysed and processed for scintillation counting as described for 45 Ca 2ϩ uptake. Confocal Microscopy-An inverted Nikon microscope equipped with the 1024 MRC Bio-Rad laser confocal system was used for fluorescence studies. For ratiometric determination of cytosolic [Ca 2ϩ ] i DRG cultures were preloaded with 5 M Indo-1 AM dye. After incubation for 30 min at 34°C, the cells were washed three times in HCB to remove excess dye and kept in the dark for at least 15 min before starting the experiments. The recordings were carried out in 1 ml of HCB. The ratio of emitted fluorescence intensity at 405 and 485 was calculated from images taken at 10-s intervals. Following of recording of the base line, the drug was added in 100 l of HCB.
To monitor the consequence of drug treatments and the effect of Ca 2ϩ on intracellular membranes, cells were transfected with VR1eGFP. After 1 day and just before microscopy they were loaded with 0.5 M MitoTracker dye as recommended by the manufacturer (Molecular Probes). Mitochondria and VR1eGFP were observed in live cells by dual fluorescence confocal microscopy employing appropriate filter sets to separate green (VR1eGFP) and red (MitoTracker) epifluorescence. To facilitate drug treatment, the experiments were performed in an open chamber system. Western Blotting-Total protein extracts were prepared in denaturing SDS buffer and analyzed for immunoreactivity by Western blotting as described previously (36) . VR1-specific antibody was raised in rabbits immunized with the N-terminal MEQRASLDSEESESPPQE pep-
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tide of rat VR1 conjugated to keyhole limpet hemocyanin. Antigen affinity-purified antibody was diluted 1000-fold for Western blot and immunocytochemistry experiments. This antibody preparation recognizes native rat VR1, as illustrated in Fig. 8 , and chimeric VR1eGFP (35) . Stripping of nitrocellulose blotting filters (Bio-Rad) was carried out in 200 ml of 50 mM Tris-HCl buffer (pH 7.5) containing 2% SDS and 0.1 M ␤-mercaptoethanol at 65°C for 1 h. To demonstrate the eGFP portion of VR1eGFP, blots were incubated either with GFP specific rabbit antiserum (CLONTECH) and then with a cytochrome c-specific monoclonal antibody as suggested by the manufacturer (PharMingen International) to assess equality of protein loading and transfer. Enhanced chemiluminescence was used to visualize primary antibody binding according to the manufacturer's protocol (New England Biolabs). Materials-ANA (1:4 soy bean oil:water emulsion), olvanil (OLV) and RTX were purchased from Tocris. ANA in ethanol, 12(S)HPETE, 12(S)HETE, PGE 2 , and PGD2 were from Biomol, and CPZ and CAP were obtained from Calbiochem. 45 Ca was from ICN, and [ 3 H]ANA was purchased from ARC.
RESULTS
Concentration-response curves from rat DRG cultures indicated that acidic pH markedly enhanced the actions of ANA on Ca 2ϩ uptake (Fig. 1a) . At pH 5.5 and 6.0 the EC 50 values of ANA-induced Ca 2ϩ transport were determined from Hill plots fitted to the data to be 7 and 10 M, respectively. At pH Ն 6.5, Ca 2ϩ uptake in DRG cells did not increase with increasing ANA concentrations, although the base-line Ca 2ϩ uptake was higher at pH 6.5 than at pH 7.0. Application of the highest concentration of vehicle (1:10 dilution of the 1:4 soy oil:water emulsion stock) was without effect on cultured DRG neurons (not shown). The observed effect of ANA was specific to primary nociceptive neurons. No similar pH-dependent, ANA-induced Ca 2ϩ uptake was found in embryonic rat spinal cord cultures. In fact, in spinal cord cultures a decrease in pH alone (i.e. pH 5.5) inhibited the short term (10 min) Ca 2ϩ uptake. Furthermore, treatment of spinal cord cultures with the same amounts of ANA did not induce Ca 2ϩ transport (not shown). In NIH 3T3 cells stably expressing VR1⑀, Ca 2ϩ uptake assays were carried out at similar pH and ANA concentrations. As with the DRG neurons, ANA treatment at progressively lower pH produced progressively more Ca 2ϩ uptake (Fig. 1b) . The EC 50 values of ANA were comparable with those of the DRG neurons: 14 Ϯ 5, 25 Ϯ 5, and 63 Ϯ 12 M, at pH 5.5, 6.0, and 6.5, respectively, indicating an increasing affinity of VR1 toward ANA at lower pH. At pH Ն 7.0 little or no effect was found with increasing ANA concentration (Fig. 1b) . In the parental NIH 3T3 cell line, in repeated experiments, H ϩ , ANA, and the vehicle (soy oil:water (1:4) emulsion at a 1:10 dilution) had no effect on basal Ca 2ϩ uptake (not shown). The vehicle also did not affect Ca 2ϩ uptake in NIH 3T3 cells expressing VR1⑀.
We next compare at pH 6.0, under mildly acidic conditions, the efficacy of ANA to RTX and CAP, which are known vanilloid agonists. In primary DRG cultures nanomolar RTX or 0.5 M CAP induced ϳ15-20-fold elevation over the basal Ca 2ϩ uptake. Under the same experimental conditions, ANA was effective in the 10 -100 M range, increasing the influx levels more than 3-fold over basal Ca 2ϩ uptake (Fig. 2a) . The induction of Ca 2ϩ uptake by 0.01 M RTX, 1 M CAP, and 100 M ANA was almost completely inhibited by 10 M CPZ, a VR1 antagonist (Fig. 2a) . Treatment with maximal amounts of vanilloid vehicle (i.e. final concentration of 0.05% EtOH added with CAP and CPZ) was without effect on the cultured DRG neurons (not shown).
The results determined in DRG cultures were compared with VR1-mediated Ca 2ϩ uptake in cells transiently expressing VR1eGFP (35) . The expression levels of VR1eGFP can be estimated in situ by fluorescence microscopy, which showed that VR1eGFP-transfected cells represented ϳ30% of the population. In Fig. 2b 45 Ca 2ϩ uptake experiments in HEK293 cells transiently expressing VR1eGFP are shown. These cultures were treated with increasing concentrations of CAP, RTX, and ANA during the 10-min period of the 45 Ca 2ϩ uptake assay. The uptake kinetics of the transfected HEK293 cells were similar to those determined in primary DRG culture (Fig. 2a) . In both cultures, vanilloids increased the 45 Ca 2ϩ uptake more than 10-fold over base line in nanomolar to micromolar concentrations. In comparison, ANA was somewhat more effective in DRG neurons. At pH 6.0 ANA stimulated 45 Ca 2ϩ uptake about 5-10-fold in the 10 -100 M concentration range. The EC 50 determined for RTX, CAP, and ANA were about 1.0, 200, and 30,000 nM, respectively (Fig. 2b) . Similar results were obtained with transiently transfected COS7 cells expressing VR1eGFP (not shown). Nontransfected HEK293 or COS7 cells did not show any increase in 45 Ca 2ϩ uptake in response to these compounds. In the absence of drug treatment, expression of VR1eGFP in different cell lines usually doubled the basal 45 Ca 2ϩ uptake, an effect most likely caused by spontaneous channel activity of VR1 (data not shown).
H ϩ dependence of RTX-and ANA-induced Ca 2ϩ uptake was studied in side-by-side experiments (Fig. 3) using the NIH 3T3 cell line stably expressing VR1⑀. Ca 2ϩ uptake assays were carried out in buffered HCBTM in which the pH was adjusted between 7.5 and 5.5 with 1 M MES, as described under "Exper- uptake medium was adjusted with 20 mM Tris-MES buffer as indicated. 45 Ca 2ϩ uptake assays were performed for 10 min at 24°C. The aliquots of solubilized cell extracts were counted in a liquid scintillation counter. Each point on the graph is the average of triplicate determinations. The experiments were repeated at least two additional times in triplicate with similar results.
Vanilloid Receptor 1 Activation by H
ϩ and Eicosanoidsimental Procedures." Nanomolar RTX and micromolar ANA induced Ca 2ϩ uptake at both high and low pH, although with different characteristics. At pH 5.5 ANA was a full agonist of VR1 and produced maximal transport comparable with nanomolar concentrations of RTX. At pH 7.5, RTX exhibited a lower affinity but produced a much higher maximal Ca 2ϩ uptake. ANA at this pH, even at a 70 M concentration, had very low affinity and capacity. These data suggest that VR1 can be protonated and that protonation substantially alters the channel function of VR1. Nontransfected NIH 3T3 cells did not respond to these ligands or acidification of the medium.
The activity of other eicosanoids with structural similarity to ANA and the ability of CPZ to antagonize their activity were examined using Ca 2ϩ uptake experiments in primary DRG cultures. The rank order of activity of four eicosanoids was 12(S)HPTE Ͼ PGD 2 Ͼ PGE 2 , with 12(S)HETE being inactive. Like ANA, these compounds activated 45 Ca 2ϩ uptake in the micromolar range (5 M each in this experiment). For each active eicosanoid, the induced 45 Ca 2ϩ uptake was completely inhibited by co-treatment with 10 M CPZ, indicating the vanilloid receptor specificity of the uptake (Fig. 4) .
The (Fig. 5a ). This transport/metabolic process was insensitive to competition by either RTX (1 or 10 nM), CAP (1 or 10 M), or CPZ (1 or 10 M). Only OLV, an analog of both vanilloids and cannabinoids produced an inhibition of [ 3 H]ANA binding: no competition at 7 M and partial competition at 70 M (not shown). The latter data suggest that the transport/metabolic process of these cells is capable of interacting specifically with ANA even at 4°C but not with vanilloids.
When VR1eGFP was transiently expressed, [ 3 H]ANA binding was augmented about 2-3-fold above the nontransfected control (first bar in Fig. 5a ), demonstrating the interaction of ANA with VR1 (Fig. 5b) . Co-incubation of 70 M nonlabeled ANA, as well as 1 or 10 nM RTX, 1 or 10 M CAP, and 0.5 M OLV displaced 54, 18, 38, 9, 27, and 32% of [ 3 H]ANA, respectively. Displacement of [ 3 H]ANA either with vanilloids or ANA strongly supports the view that ANA binds to VR1, whereas the inability of vanilloids to interfere with ANA at the cannabinoid transport/metabolic system distinguishes it from VR1 (Fig. 5  legend) .
The experiments above demonstrated that ANA can induce Ca 2ϩ uptake at acidic conditions (pH Յ 6.5) in DRG neurons and in cells ectopically expressing VR1 recombinants. To address the effects of ANA and pH on intracellular free Ca uptake experiments. To demonstrate VR1 specificity, 10 M capsazepine, a vanilloid antagonist, was added simultaneously with the indicated concentrations of ligands (filled symbols). Capsazepine in this concentration almost completely blocked the VR1-specific responses, determined with co-incubation with 10 nM RTX, 1 M CAP, and 100 M ANA in both DRG cultures and HEK293 expressing VR1eGFP. Each point represents the mean ϩ S.E. of triplicate determinations. Similar results were obtained in two independent experiments also performed in triplicate.
FIG. 3. H
؉ dependence of ANA-and RTX-induced VR1-mediated Ca 2؉ uptake. NIH 3T3 cells stably expressing VR1⑀ were seeded in 24-well plates 1 day before the experiment. Ca 2ϩ uptake assays were carried out in buffer adjusted to pH 5.5 and 7.5, as indicated. At pH 5.5 both ligands induced a VR1-mediated high affinity and low capacity form of Ca 2ϩ uptake. At neutral pH, RTX has a lower affinity but induces a much higher capacity Ca 2ϩ uptake, whereas ANA was nearly ineffective. Each experiment was repeated at least two additional times in triplicate with similar results.
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view showed no change in fluorescence ratio over time and no response upon addition of ANA. Subramanian and Meyer demonstrated that elevation of [Ca 2ϩ ] i with either the Ca 2ϩ ionophore, ionomycin, or thapsigargin, an inhibitor of the SERCA ATPase involved in reuptake of Ca 2ϩ to the ER, caused fragmentation of the ER (32). We utilized this fragmentation effect in a previous report examining vanilloid-induced Ca 2ϩ influx, and it provides a robust end point for optically based determinations of VR1 agonist activity. We also demonstrated that the normally filamentous mitochondria undergo vesiculation concurrently with the ER upon abrupt elevation of [Ca 2ϩ ] i (35) . These ligand-activated processes were examined in cultures expressing VR1eGFP (green) preloaded with the MitoTracker dye (red), which is a vital fluorescent marker of mitochondria. The cells were then imaged by dual wavelength fluorescent confocal microscopy. In ] i determined by ratiometric confocal imaging of DRG neurons. Individual DRG neurons were selected, and their perikarya were marked for ratiometric imaging in the field of a 40ϫ objective. Following base-line recording, 100 l of ANA was added to make a 35 M final concentration in the HCB medium (pH 6.0), at the indicated time point. The ratio of emitted fluorescence intensity at 405 and 485 was calculated simultaneously from selected large (ϳ1000 m 2 ) and small size (ϳ250 m 2 ) neurons; the latter population contains the C-fiber nociceptors, which express VR1. The data shown are from a field of view containing five neurons. The curve showing the increase in ratio is from three small size neurons exhibiting a Ca 2ϩ response (symbols represent the means of emitted fluorescence ratio Ϯ S.E.). The lower curves are recordings from the two large size neurons that did not show an elevation in fluorescence ratio.
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addition to functioning at the plasma membrane as a Ca 2ϩ ionophore (Figs. 1-4) , VR1eGFP is also present in the ER in COS7 (Fig. 7a) , HEK293, and NIH 3T3 cells (35) . This localization provides the fluorescent label for the ER compartment in the present experiments, which were done in COS7 cells (Fig. 7) . Application of 1 nM RTX, 5 M OLV, and 70 M ANA induced a rapid (Ͻ30 s) fragmentation of the intracellular membranes. The effect was similar with ANA, OLV, or RTX. Changes included transformation of the ER network into vesicles and rounding up of the mitochondria. Additional hallmarks of Ca 2ϩ cytotoxicity were observed, such as nuclear envelope blebbing (Fig. 7, b, c, and d versus a) and rounding up the cells after ϳ1 h (not shown, illustrated in Ref. 35 ). None of these drug effects were noted in adjacent nontransfected cells, which are only stained red with the MitoTracker dye (Fig. 7a) . The intracellular fragmentation was only seen upon agonist treatment in VR1-transfected cells. At least five experiments were performed with each drug, and all VR1eGFP-positive cells that we observed underwent ER and mitochondrial remodeling. These data strongly suggest that sensitivity to vanilloids and eicosanoids was solely conferred by ectopic expression of VR1 in the heterologous cells.
To simulate tissue acidification, cells were cultured in complete DMEM in the absence of HEPES buffer for 24 h. Under these conditions the pH gradually drops to 6.0 Ϯ 0.5, determined in repeated experiments, and the DRG cultures were incubated for additional 24 h in the presence of 25 nM RTX, 50 M OLV or 70 M ANA. Western blot analysis in Fig. 8 shows a typical result of these treatments. All three drugs substantially reduced VR1 immunoreactivity compared with untreated cells. The blots, prepared from the primary DRG cultures, were stripped and reprobed with an anti-cytochrome c antibody (Fig.  8a, Cyt. c) . Densitometric scans demonstrated little or any decrease in the cytochrome c levels despite the fact that the cultures exhibited 99, 74, and 75% losses of VR1-specific immunoreactivity after OLV, RTX, and ANA treatment, respectively (Fig. 8b) . Withdrawal of HEPES buffer from the DRG culture medium for 48 h did not significantly reduce either the levels of VR1 or cytochrome c of nontreated cells (not shown). The selective loss suggests that vanilloid agonists and ANA effectively removed the subpopulation of VR1-positive cells from the primary cultures, a result consistent with the imaging studies performed in VR1eGFP-expressing cells (Fig. 7) .
DISCUSSION
The present report provides evidence that eicosanoids, particularly the endocannabinoid, anandamide, bind to VR1 and activate Ca 2ϩ uptake in specific DRG neurons in a pH-dependent manner. Small size neurons in the DRG uniquely express VR1, which is also known to be sensitive to acidification of the extracellular milieu (6 -8, 10) . To date the vanilloid-agonist activity of ANA (i.e. actions antagonized by CPZ) has been demonstrated only in a vasodilatation model in animals (17, 39) . The direct [ 3 H]ANA binding studies on VR1-expressing cells extend these observations and provide evidence that ANA, in addition to the CB1 and CB2 receptors, binds to VR1 and is displaced with vanilloid compounds. We demonstrate that ANA binding to VR1 activates Ca 2ϩ transport in a pH-dependent fashion in dissociated DRG neuron cultures and in cells ectopically expressing VR1 (Fig. 1) . By themselves, neither the DRG cultures nor the VR1-expressing cell lines responded to acidification of the milieu with Ca 2ϩ uptake. Likewise, vanilloids and CPZ had no effect on nontransfected cells. However, CPZ 
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inhibited Ca 2ϩ uptake in DRG neuron cultures or the VR1-expressing cell systems when co-incubated with either vanilloids or ANA (Fig. 2) . Our data also suggest that a pH of Յ6.5 can change VR1 into a conformation distinct from that at pH 7.5. The acidic conformation promotes ANA-induced Ca 2ϩ uptake in VR1-expressing cells (Fig. 3) . A previous work studied ANA activation of human VR1-mediated Ca 2ϩ uptake at pH 6.4 and 7.4 and consequently was only able to employ heterologous expression systems (28) . The present evidence demonstrates that acidification potentiates the activity of ANA and perhaps other eicosanoids at rat VR1. In addition to ANA, products of lipoxigenases, including endogenous capsaicin-like substances such as 12-and 15-(S)-hydroperoxyeicosatetraenoic acids, 5-and 15-(S)-hydroxyeicosatetraenoic acids, and leukotriene B (4), also activate VR1 expressed in HEK293 cells (4) using electrophysiological methods, a result we extend with Ca 2ϩ uptake and [ 3 H]ANA binding. Taken together, the data in this paper and recent observations support the view that certain products of lipoxigenases and ANA under acidic conditions can serve as endogenous ligands of VR1. The combined effect of high eicosanoid release and low pH might contribute to pain signaling to the CNS in vivo.
Previously, acidification was noted to sensitize nociceptive neurons toward vanilloids (40, 41) and eicosanoids including, but probably not confined to, PGE 2 and prostacyclin (18, 20, 21, 42, 43) . In addition to acid-sensitive sodium ion channels (44 -46) , recent point mutation studies implicate H ϩ as a direct regulator of VR1. Acidification of the extracellular medium apparently exerts its effects on the Glu 600 residue located in the pore loop region of VR1. This region may be distinct from the putative binding site(s) of lipid ligands, which remains to be elucidated (10). Here we provide further evidence that an acidic environment dramatically changes the affinity and transport kinetics of VR1 in transfected cells or DRG neurons (Figs. 1-3) . The kinetic parameters of ligand-induced activation in Fig. 3 suggest that association/dissociation of H ϩ with VR1 at the cell surface changes VR1 into high and low affinity forms, respectively. Low pH promotes while neutral pH inhibits the efficacy of ANA to activate VR1 ( Fig. 3 ; high affinity Ca 2ϩ uptake with low V max , at pH 5.5 and vice versa at 7.5).
In (17, 48, 49) . The potent blockade of eicosanoid-induced Ca 2ϩ uptake by CPZ determined here and observations made earlier (4, 17) imply that inflammatory metabolites of the lipoxigenase and cyclooxygenase pathways might activate VR1 in vivo.
Transmembrane transport of ANA was reported in different cell types including neurons, astrocytes, and liver cells (37, 50, 51 ). An intracellular hydrolase, tightly coupled to the transporter, which splits ANA to arachidonic acid and ethanolamine, was characterized in a wide variety of cells (37, 38) . Through heterologous expression of VR1, we were able to differentiate between ANA transport/metabolism and ANA binding to VR1 as well as its ability to functionally elicit specific Ca 2ϩ uptake. The ratio imaging of ANA-induced increases in [Ca 2ϩ ] i in DRG neurons clearly showed specific stimulation of VR1 ionophore activity, which corroborates the observations of others employing electrophysiological techniques (17, 18) . Ca 2ϩ -induced transient disruption of ER can occur under conditions of physiological stimulation, such as reported for fertilization of oocytes (52) . Here we show that ANA, like vanilloids (35), promotes rapid intracellular membrane remodeling of the ER and morphological transformation of mitochondria (Fig. 7) . These changes can lead to cell death, whereas at injury sites remote from the cell body, such processes may damage VR1-positive axons or nerve terminals. To avoid cytotoxicity, even under less extreme situations in vivo, VR1-positive nociceptors probably are endowed with precise regulation of [Ca 2ϩ ] i (53-55), including high capacity scavenger functions of mitochondria (56, 57) , although in vivo, eicosanoids seems to affect only the protonated form of VR1, which likely confines these actions to inflamed or ischemic tissues. Protonated VR1 may start to react to Յ1 M concentrations of eicosanoids or to particular mixtures of these substances (i.e. "inflammatory soup") (58). PGE 2 was reported to potentiate the effects of suboptimal concentrations of CAP (48, 49) . It is also conceivable that in pathological situations eicosanoids may temporally reach micromolar levels, as observed (59) . ANA in that concentration probably is effective not only on conventional receptors such as CB1 or CB2 but on VR1 presented by C-type fibers of polymodal nociceptors all over the body, including the skin and internal organs. In fact, it is known that inflammatory conditions can recruit populations of "silent nociceptors," which are only active in the presence of inflammatory mediators (60) .
In summary, ANA and other eicosanoids can interact with VR1 in a fashion similar to vanilloids, although with much lower affinity. [ 3 H]ANA binds to VR1 expressed in heterologous cell systems and is displaced by vanilloids, suggesting competitive interaction with VR1. The data in this paper implicate FIG. 8 . Western blot analysis of DRG cultures treated with vanilloids and ANA. DRG cultures were prepared as described under "Experimental Procedures" and plated in complete DMEM containing 20 mM HEPES (pH 7.4) in 24-well plates. After 2 days, cells were changed into complete DMEM prepared without HEPES buffer and cultured for an additional 24 h. After 24 h the pH levels of the supernatants of the cultures were determined to be 6.1 Ϯ 0.4, and then 25 nM RTX, 50 M OLV, or 70 M ANA was added. After 24 h DRG cultures were harvested in 50 l denaturing SDS lysis buffer. Total protein extracts (15 g from each sample) were analyzed by Western blotting. The blots were probed first with an affinity-purified antibody raised against the first 18 amino acids of rat VR1. The immunoreactive bands were visualized by enhanced chemiluminescence on x-ray film. The top arrow points toward the immunoreactive 93-kDa band specific to VR1. All three drugs substantially reduced VR1 immunoreactivity compared with control DRG cultures (panel a, upper section). To demonstrate equal protein loading, the same blot was stripped and reprobed with a cytochrome c-specific (Cyt. c) antiserum (panel a, lower section). VR1 and cytochrome c specific bands were scanned, and the optical density (OD) was quantitated by the NIH Image software (panel b). The data presented are from the same batch of DRG cultures distributed in a 24-well plate for different treatments. Similar results were obtained from two additional batches of DRG cultures analyzed in duplicate.
Vanilloid Receptor 1 Activation by H
ϩ and Eicosanoidsendogenous arachidonic acid derivatives, including ANA, as conditional, endogenous ligands of vanilloid receptor(s). Eicosanoids and H ϩ , overproduced in pathological situations potentiate each other to trigger VR1 exposed on nociceptive neurons. Eicosanoids and protons released by noxious heat, mechanical, and ischemic injury as well as inflammation may stimulate pain transmission through this mechanism.
